0001213900-23-019387.txt : 20230313 0001213900-23-019387.hdr.sgml : 20230313 20230313080021 ACCESSION NUMBER: 0001213900-23-019387 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230310 FILED AS OF DATE: 20230313 DATE AS OF CHANGE: 20230313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COLEMAN KIRK ALLEN CENTRAL INDEX KEY: 0001790624 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39102 FILM NUMBER: 23725758 MAIL ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001733413 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824344737 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 737-802-1973 MAIL ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 4 1 ownership.xml X0306 4 2023-03-10 0 0001733413 TFF Pharmaceuticals, Inc. TFFP 0001790624 COLEMAN KIRK ALLEN 1751 RIVER RUN, SUITE 400 FORT WORTH TX 76107 0 1 0 0 Chief Financial Officer Common Stock 2023-03-10 4 P 0 12000 0.7881 A 15675 D The reported shares were purchased in the open market in multiple transactions at prices ranging from $0.7848 to $0.7888. The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to TFF Pharmaceuticals, Inc., any stockholder of TFF Pharmaceuticals, Inc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). /s/ Kirk Allen Coleman 2023-03-13